We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,092

Antitrust and Competition - The EU Weekly Briefing (10 October 2016)
  • Winston & Strawn LLP
  • China, Croatia, European Union, United Kingdom
  • October 10 2016

On 7 October 2016 the Commission made full use of the measures available in anti-dumping legislation (here and here), by imposing provisional

Expect the unexpected Patenting antibodies in Asia
  • FB Rice
  • China, Japan, South Korea
  • September 6 2016

Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to

Ramping up of antitrust enforcement in the Chinese pharmaceutical sector
  • Freshfields Bruckhaus Deringer LLP
  • China
  • August 23 2016

China's National Development and Reform Commission (NDRC), one of

China Newsletter, Summer 2016 No. 34
  • Greenberg Traurig LLP
  • China
  • August 10 2016

On March 23, 2016, the State Administration of Taxation (the Tax Bureau) and Ministry of Finance released the Notice of Overall Pilot Execution of

Pharmaceutical trademark protection in China
  • Kangxin Partners PC
  • China
  • July 11 2016

Author: Yu Li The rise in IP litigation involving pharmaceutical trademarks, generic drug names and commodity names suggests that rights holders

China: Trademark registration: a secret weapon
  • Kangxin Partners PC
  • China
  • July 1 2016

Unlike patents, registered trademarks benefit from 10 years of protection and unlimited renewals, making them a valuable tool when it comes to

Corporate Crime & Investigation Update - 1 July 2016
  • Addleshaw Goddard LLP
  • Chile, China, European Union, France, South Africa, United Kingdom, USA
  • July 1 2016

Chinese state media has reported that Chinese prosecutors accused Zhang Lijun, a former deputy environment minister, of taking 2.4 million yuan ($361

The coenzyme Q10 “saga”
  • HFG Law & Intellectual Property
  • China
  • June 13 2016

In the fast-evolving world of food and health-food regulation, two recent court decisions deserve our attention as they rule in opposite direction a

Corporate Crime Update - March 2016 - United States
  • Herbert Smith Freehills LLP
  • China, Cuba, USA, Uzbekistan
  • March 31 2016

We reported in December that VimpelCom, the Dutch telecommunications company, made $900 million Accounting provision relating to bribery

美国的医疗器械知识产权保护 -中国公司的应对策略
  • Han Kun Law Offices
  • China, USA
  • March 28 2016

对那些在美国市场推出医疗器械产品的中国企业而言保护产品知识产权的秘密在于理解所有 124 可行条件125 选择最适合贵司医疗器械的知识产权保护类型十分